Latest Cystic fibrosis Stories
Collaborative Forum to Focus on Promising Advances in Drug Development, Research and Care for People with CF ATLANTA, Oct.
ChanTest’s expertise will be showcased at the North American Cystic Fibrosis Conference this month, highlighting the important research the company has conducted to help move cystic fibrosis
Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct.
NEW YORK, Oct.
Innovative Treatment to Improve Lung Function and Antibiotic Effectiveness in CF Patients Claremont, CA (PRWEB) October 02, 2014 Cystic fibrosis (CF)
LAUSANNE, Switzerland, October 1, 2014 /PRNewswire/ -- Sophia Genetics, the European leader in Clinical Genomics and Next Generation Sequencing (NGS) data analysis, today
Patients with chronic obstructive pulmonary disease (COPD) report improved symptoms and health status when they use a hand-held respiratory device called the Lung Flute®
Claire Wineland receives notable award for her dedication to making a difference in the lives of others living with cystic fibrosis Los Angeles, CA (PRWEB) September
Expanded Collaboration Supports Phase 2 Clinical Trial Initiation of First-In-Class ENaC Inhibitor for the Treatment of Cystic Fibrosis DURHAM, N.C., Sept.
Storage.com and Boomer Esiason Foundation will work together in September & October to raise funds to fight cystic fibrosis.
Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.